相关实验视频
Updated: Jun 23, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
548
人工智能应用于慢性病矿物质骨疾病的应用
Eleanor D Lederer1,2,3, Mahmoud M Sobh4, Michael E Brier3,5
1VA North Texas Health Care Services, Dallas TX, USA.
Clinical kidney journal
|June 20, 2024
概括
慢性病矿物质和骨疾病 (CKD-MBD) 加快死亡率. 本综述建议使用人工智能和数学建模来开发新的CKD-MBD疗法和诊断工具,以获得更好的患者结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物数学是生物数学.
- 人工智能的人工智能
背景情况:
- 慢性病-矿物质和骨疾病 (CKD-MBD) 显著增加了病患者的死亡率.
- 目前用于CKD-MBD的治疗方法,包括透析,酸盐结合剂和二次性甲状腺功能障碍症的治疗方法,并没有改善心血管结果.
- 由于对病理生理学的不完全理解,缺乏早期临床点,以及不同的临床表现,进步受到阻碍.
研究的目的:
- 通过整合数学建模和机器学习人工智能来引入CKD-MBD的新方法.
- 探索AI在产生新假设和开发CKD-MBD创新的治疗策略方面的潜力.
- 解决对更好的诊断工具,风险评估和针对CKD-MBD的个性化治疗的需求.
主要方法:
- 审查目前对CKD-MBD的理解和治疗限制.
- 拟议框架的描述,将生物过程的数学建模与机器学习AI相结合.
- 人工智能的应用用于假设生成和开发新型治疗方法.
主要成果:
- 拟议的方法为克服CKD-MBD研究和治疗当前障碍提供了一条途径.
- 人工智能和数学建模可以加速识别新的治疗点和个性化治疗策略.
- 整合人工智能可以提高CKD-MBD患者的诊断能力和风险分析.
结论:
- 结合数学建模和人工智能的新方法对推进CKD-MBD研究具有重大前景.
- 人工智能集成对于开发创新的诊断和个性化治疗来改善病患者的治疗结果至关重要.
- 这种跨学科的方法可以加速管理CKD-MBD复杂性的进展.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
Renal Failure: Dose Adjustments
80
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
80

